Volume 14, Number 7—July 2008
Research
Testing for Coccidioidomycosis among Patients with Community-Acquired Pneumonia
Table 3
Characteristic | Case-patients, no. (%), n = 60 | Controls, no. (%), n = 76 | Odds ratio (95% CI) | Adjusted odds ratio† (95% CI) |
---|---|---|---|---|
Age >18 y | 53 (88) | 44 (58) | 5.5 (2.1–15.3)‡ | 5.3 (1.5–24.0) |
Male | 28 (55) | 40 (53) | 0.9 (0.5–1.9) | NS |
Chest pain | 19 (32) | 7 (9) | 4.6 (1.8–11.8)‡ | 3.9 (1.2–13.8) |
Rash | 5 (8) | 0 | Undefined (1.2–Undefined)‡ | 21.1§ (2.2–undefined) |
Diabetes mellitus or immunosuppressive condition | 10 (17) | 4 (5) | 3.6 (1.0–16.5)‡ | NS |
Symptoms >14 d | 20 (33) | 6 (8) | 5.8 (2.1–15.7)‡ | 4.1 (1.3–14.2) |
*CI, confidence interval; NS, not significant. Case-patients were patients who had CAP and had received Coccidioides spp. serologic testing, regardless of test result; controls were patients who had CAP but had not received Coccidioides spp. serologic testing.
†Adjusted odds ratios and exact 95%CI from a multivariable logistic regression model.
‡Significant (p<0.05) according to univariate analysis.
§Median unbiased estimate of the adjusted odds ratio.
Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.